UnlockNovo Nordisk receives Investment Bank Analyst Rating Update
- Investing.com
Pro- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Novo Nordisk A/S (NVO)
137.00
+0.34(+0.25%)
Closed
After Hours
137.25+0.25(+0.18%)
Fair Value
An estimate of a stock's true price based on valuation of 49 models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
136.37
137.89
52 wk Range
86.96
148.15
NVO Scorecard
Full Analysis
Has raised its dividend for 7 consecutive years
Assess today's live Novo Nordis (NVO) share price, performance and insights using our live NYSE: NVO stock exchange data.
Analyse the historical data and Novo Nordis share price performance charts on this page. Our technical summary section provides analysis on Novo Nordisk ADR share price buy/sell indicators using real-time data (or discuss the Novo Nordisk ADR (NVO) stock price today with other investors in the Novo Nordisk ADR NYSE share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NYSE NVO share price (ISIN: US6701002056) to enhance your trading decisions with our free investment tools and resources.
What Is the Novo Nordis Share Price Today?
The Novo Nordisk ADR share price today is 137.00.
What Is the Stock Symbol for Novo Nordis
The stock symbol (or 'ticker') for Novo Nordisk A/S is "NVO."
What Stock Exchange Does Novo Nordis Trade On?
Novo Nordisk A/S is listed and trades on the NYSE stock exchange.
Is Novo Nordis a Good Stock to Buy?
Determining whether Novo Nordisk A/S—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Novo Nordis share price performance charts on this page. Our technical summary section provides analysis on Novo Nordisk ADR share price buy/sell indicators using real-time data (or discuss the Novo Nordisk ADR (NVO) stock price today with other investors in the Novo Nordisk ADR NYSE share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NYSE NVO share price (ISIN: US6701002056) to enhance your trading decisions with our free investment tools and resources.
What Is the Novo Nordis Share Price Today?
The Novo Nordisk ADR share price today is 137.00.
What Is the Stock Symbol for Novo Nordis
The stock symbol (or 'ticker') for Novo Nordisk A/S is "NVO."
What Stock Exchange Does Novo Nordis Trade On?
Novo Nordisk A/S is listed and trades on the NYSE stock exchange.
Is Novo Nordis a Good Stock to Buy?
Determining whether Novo Nordisk A/S—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Fair Value
An estimate of a stock's true price based on valuation of 49 models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
136.37137.89
52 wk Range
86.96148.15
NVO Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation of 49 models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Buy
Price Target
974.60
Upside
+611.39%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
4 analysts have revised their earnings downwards for the upcoming period
- Novo Nordisk ADRs Continue Gains, Up ~3.5% Now
- Investing.com
Pro - Novo Nordisk receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Novo Nordisk shares rise on robust trial results
- Investing.com
- Novo Nordisk receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Novo Nordisk receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Novo Nordis receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Novo Nordisk ADR Company Profile
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with Aspen Pharmaceuticals to produce insulin products. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Compare NVO to Peers and Sector
Metrics to compare | NVO | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipNVOPeersSector | |
|---|---|---|---|---|
P/E Ratio | 45.3x | 13.2x | −0.6x | |
PEG Ratio | 1.30 | 0.20 | 0.00 | |
Price/Book | 36.2x | 3.3x | 2.6x | |
Price / LTM Sales | 15.8x | 3.0x | 3.1x | |
Upside (Analyst Target) | 16.1% | 1.2% | 55.7% | |
Fair Value Upside | Unlock | 11.4% | 6.8% | Unlock |
People Also Watch
FAQ
What Is the Novo Nordisk ADR (NVO) Stock Price Today?
The Novo Nordisk ADR stock price today is 137.00
What Stock Exchange Does Novo Nordisk ADR Trade On?
Novo Nordisk ADR is listed and trades on the NYSE stock exchange.
What Is the Stock Symbol for Novo Nordisk ADR?
The stock symbol for Novo Nordisk ADR is "NVO."
Does Novo Nordisk ADR Pay Dividends? What’s The Current Dividend Yield?
The dividend yield is 0.75%.
What Is the Novo Nordisk ADR Market Cap?
As of today, Novo Nordisk ADR market cap is 604.26B.
What is Novo Nordisk ADR Earnings Per Share?
The Novo Nordisk ADR EPS is 20.14.
What Is the Next Novo Nordisk ADR Earnings Date?
Novo Nordisk ADR will release its next earnings report on 06 Nov 2024.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.